FDA NDC Directory · JSON-LD · Markdown

UBRELVY

NDC 0023-6501 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameubrogepant
Labeler / ManufacturerAllergan, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA211765
Dosage form / routeTABLET · ORAL
Active ingredientsUBROGEPANT (100 mg/1)
Marketing started20191223
Package count4

External sources

Source: openFDA. Public-domain (CC0).